share_log

EyePoint Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC ·  Jan 23 13:00

Summary by Futu AI

EyePoint Pharmaceuticals, Inc. Director Nancy Lurker is set to sell 5,044 shares of common stock on 01/23/2024, as per the latest SEC filings. The shares to be sold have an aggregate market value of approximately $125,949.69. The securities were acquired through open market purchases and stock options between October 2019 and February 2020. This planned sale follows a previous transaction where Lurker sold 20,000 shares for a total gross proceed of $415,164 on 12/04/2023.
EyePoint Pharmaceuticals, Inc. Director Nancy Lurker is set to sell 5,044 shares of common stock on 01/23/2024, as per the latest SEC filings. The shares to be sold have an aggregate market value of approximately $125,949.69. The securities were acquired through open market purchases and stock options between October 2019 and February 2020. This planned sale follows a previous transaction where Lurker sold 20,000 shares for a total gross proceed of $415,164 on 12/04/2023.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated